An Emergency Medicine Broadsheet
·Phoenix·
Est. MMXXVI
Blue Fish Med · Today's Topic
Pertussis
Pertussis can cause apnea, hypoxemia, pneumonia, and death in young infants while appearing deceptively mild in older children and adults. Early recognition protects vulnerable contacts and prevents prolonged transmission.
A 7-year-old girl sits upright on the stretcher, cheeks flushed, eyes watering after a coughing spell that ends with a loud inspiratory gasp. Her mother reports that the episodes come in clusters, often followed by vomiting, while between spells the child looks surprisingly comfortable. The cough has lasted nearly three weeks, and tonight she briefly stopped breathing during one episode. The next decision has not yet been made.
— What’s your move? Read on.
Before you read
Who needs immediate respiratory support or admission?
When do antibiotics alter the patient’s course versus mainly interrupt transmission?
When to Think of It
Think pertussis with paroxysmal cough, inspiratory “whoop,” post-tussive emesis, cough-related syncope, or apnea—especially cough lasting ≥2 weeks without another explanation. The whoop may be absent in vaccinated patients, adolescents, adults, and infants; infants may present primarily with apnea, cyanosis, poor feeding, or bradycardia.
Sick or Not Sick
The key fork is adequate ventilation and oxygenation versus impending respiratory failure. Admit or escalate immediately for apnea, cyanosis, recurrent desaturation, exhaustion, pneumonia, dehydration, inability to feed, altered mental status, or young age—particularly infants <3 months.
The First Fifteen Minutes
Place the patient on droplet precautions; use continuous pulse oximetry and cardiorespiratory monitoring if apnea, hypoxemia, or young age is present.
Apnea, hypoxemia, or respiratory distress → oxygen by nasal cannula 1–6 L/min, titrated to age-appropriate saturation, because increased inspired oxygen corrects hypoxemia while the airway and ventilatory pattern are assessed.
Persistent apnea or inadequate ventilation → bag-mask ventilation with 100% oxygen, then prepare for intubation; ventilation, not simply oxygen, is required when the patient cannot move air.
Confirmed or strongly suspected disease, or high-risk exposure → azithromycin 500 mg PO on day 1, then 250 mg PO daily on days 2–5; it reduces nasopharyngeal bacterial burden and transmission, although it may not shorten an established cough. For infants and children, use 10 mg/kg PO on day 1, then 5 mg/kg PO daily on days 2–5; verify pediatric maximums and local protocol.
Unable to take oral therapy → azithromycin 500 mg IV daily in adults; pediatric IV dosing is weight-based and should be checked in a pediatric reference.
Severe bronchospasm with objective wheezing → albuterol 2.5 mg nebulized, because reversible bronchospasm may contribute to distress; routine bronchodilators do not treat the infection.
Obtain nasopharyngeal PCR or culture, but do not delay isolation or treatment when the clinical suspicion is high.
Definitive Care & Disposition
Send nasopharyngeal PCR during the first 3–4 weeks of cough; culture is more specific but less sensitive and is most useful early. Treat household and other high-risk close contacts with an age-appropriate macrolide, regardless of vaccination status, in consultation with public health. Keep the patient away from school, childcare, and healthcare settings until 5 days of effective antibiotics are completed, or 21 days from cough onset if untreated. Admit infants with apnea, cyanosis, feeding difficulty, hypoxemia, or recurrent paroxysms; ICU care is appropriate for recurrent apnea, escalating oxygen needs, pulmonary hypertension, or ventilatory failure.
How This One Kills
The dangerous miss is dismissing an infant’s apnea or cyanosis as reflux or a brief resolved unexplained event while paroxysmal pertussis causes recurrent hypoxemia, bradycardia, and sudden deterioration.
The Differential — What Else Looks Like This
Viral bronchiolitis — diffuse wheeze/crackles and persistent increased work of breathing rather than discrete cough paroxysms; confusing them can delay droplet isolation and contact prophylaxis.
Croup — barky cough and stridor, especially at night; confusing it can obscure a prolonged paroxysmal illness without upper-airway obstruction.
Asthma — expiratory wheeze and variable airflow limitation; confusing it can lead to repeated bronchodilators while transmission continues.
Foreign body aspiration — abrupt onset, focal wheeze, or unilateral air trapping; confusing it can delay bronchoscopy.
The Second-Day Story
In vaccinated adolescents and adults, the whoop may disappear and the illness may look like an unexplained cough lasting several weeks, sometimes with rib pain, vomiting, or syncope. In infants, the cough may be minimal or absent; apnea, cyanosis, poor feeding, or episodic bradycardia is the signal. Ask specifically about vaccination, household cough, school or childcare exposure, and cough duration, then use PCR early enough that a negative late test is not overinterpreted.
Back to Our Patient
Back to the 7-year-old girl with three weeks of paroxysmal cough, post-tussive vomiting, and a brief apnea episode: the pattern makes pertussis recognizable even without dramatic lung findings. Her oxygenation, work of breathing, hydration, mental status, and recurrence of apnea determine risk; if she is currently stable, obtain nasopharyngeal PCR, place her on droplet precautions, and give azithromycin 500 mg PO today followed by 250 mg daily for four days. Because she has had apnea, she warrants monitored observation or admission rather than routine discharge, with escalation to assisted ventilation if apnea or hypoxemia recurs; household contacts need public-health-directed prophylaxis.
Patient Presentation to Attending
How you’d present this patient on the floor — tight, pertinent positives and negatives, no rambling
“This is a previously healthy 7-year-old girl with three weeks of progressively paroxysmal cough, post-tussive emesis, and a brief apneic episode tonight. She has had no persistent fever, focal chest pain, or known aspiration event, but her mother reports a loud inspiratory gasp after several coughing fits and a coughing illness in a household contact. She is currently alert with normal work of breathing between spells, but had transient desaturation during observation and has no focal wheeze or unilateral breath sounds. My leading diagnosis is pertussis with apnea risk, with viral infection, asthma, and foreign body aspiration as alternatives. I would place her on droplet precautions, obtain nasopharyngeal PCR, start azithromycin, monitor continuously, and admit for recurrent apnea or desaturation surveillance.”
Study Directive
From memory, list the three phases of pertussis and the typical timing of PCR versus culture.
Practice calculating adult and pediatric azithromycin regimens.
Review local public-health criteria for postexposure prophylaxis and return-to-school restrictions.
Work through three apnea cases and state the precise admission/ICU trigger for each.
Mi YM, Deng JK, Zhang T, et al. · World J Pediatr, 2024 · PMID 39537933 · cited 38×
Provides a current pediatric consensus on recognizing, confirming, and treating pertussis—especially important for infants at highest risk of apnea and severe disease.
Missed pulmonary tuberculosis exposes patients and healthcare workers to an airborne pathogen and delays public-health intervention. Severe disseminated,...
A 42-year-old man sits quietly beneath a thin hospital blanket, his shirt damp at the collar despite the cool room. He has lost 9 kg over two months and now coughs up a streak of blood into a tissue. His chest radiograph shows an abnormality in the upper lung, and the triage nurse has already placed him in a busy hallway. The next move is not yet made.
Before You Read
What bedside clues should trigger airborne isolation before confirmatory testing?
Which patient with suspected TB needs immediate treatment rather than an outpatient workup?
What must be obtained before therapy, and which results can wait?
Why It Matters
Missed pulmonary tuberculosis exposes patients and healthcare workers to an airborne pathogen and delays public-health intervention. Severe disseminated, meningeal, or miliary disease can deteriorate rapidly even when the initial respiratory symptoms seem modest.
When to Think of It
Enter TB into the differential with cough ≥3 weeks, hemoptysis, fever, night sweats, weight loss, apical or cavitary disease, unexplained lymphadenopathy, or epidemiologic risk: birth or residence in an endemic region, homelessness, incarceration, shelter exposure, healthcare work, HIV, diabetes, silicosis, immunosuppression, or recent close contact.
Sick or Not Sick
The key call is stable, localized pulmonary disease versus unstable or disseminated disease. Respiratory failure, massive hemoptysis, sepsis, altered mental status, meningismus, focal neurologic deficits, pregnancy with severe illness, or significant immunocompromise requires admission and specialty consultation; suspected infectious pulmonary TB requires airborne isolation regardless of apparent stability.
The First Fifteen Minutes
Move to an airborne infection isolation room; staff use fit-tested N95 or higher-level respiratory protection. This reduces aerosol transmission before the diagnosis is proven.
Hypoxemia → oxygen by nasal cannula 1–6 L/min, titrated to target saturation; oxygen supports gas exchange while the infectious workup proceeds.
Massive hemoptysis with airway compromise → endotracheal intubation using a cuffed tube and lung isolation strategy, with anesthesia/critical-care support; oxygenation and airway protection take priority.
Obtain sputum for three specimens, ideally 8–24 hours apart with at least one early-morning sample, for AFB smear and culture, plus rapid molecular testing on an initial specimen. Induced sputum or bronchoscopy may be required.
High clinical suspicion for active TB with unstable disease, disseminated disease, or meningitis → after collecting diagnostic specimens, start empiric four-drug therapy: isoniazid 5 mg/kg PO daily, maximum 300 mg, rifampin 10 mg/kg PO daily, maximum 600 mg, pyrazinamide 25 mg/kg PO daily, maximum 2 g, and ethambutol 15–20 mg/kg PO daily, maximum generally 1.6 g. These inhibit organisms at multiple sites and reduce resistance; dosing must be checked against Lexicomp, UpToDate, or the local TB protocol, particularly with renal or hepatic dysfunction.
Give pyridoxine 25–50 mg PO daily with isoniazid, because it reduces peripheral neuropathy risk; use higher prophylactic dosing in selected high-risk patients per TB guidance.
Do not delay treatment in a critically ill patient for susceptibility testing, but involve infectious disease and public health immediately.
Definitive Care & Disposition
Notify the health department and arrange directly observed therapy or the local equivalent. Confirm active disease with culture and susceptibility testing; rapid molecular testing can identify M. tuberculosis and rifampin resistance sooner. Evaluate for HIV and extrapulmonary involvement, including CNS disease when symptoms warrant. Stable patients still require isolation and a coordinated TB evaluation; discharge is appropriate only when clinically safe and public-health authorities agree that housing, follow-up, medication access, and exposure control are reliable. Respiratory failure, severe hemoptysis, miliary disease, TB meningitis, or shock requires ICU-level care.
How This One Kills
The lethal and contagious miss is sending a stable-appearing patient with cavitary disease back to a shelter or crowded home without airborne isolation, sputum testing, and public-health coordination.
The Atypical Presentation
Older adults may have fatigue, anorexia, confusion, or decompensation of chronic disease without fever or prominent cough. People with HIV or other immunosuppression may have lower-lobe, diffuse, adenopathic, or miliary patterns rather than an apical cavity. In a patient with compatible risk and an unexplained infiltrate, the absence of classic imaging should not lower the priority of airborne isolation.
Back to Our Patient
Back to the 42-year-old man with weight loss, night sweats, hemoptysis, and an upper-lobe abnormality: the combination should trigger suspected pulmonary TB immediately. His first risk decision is whether he is stable or has hemoptysis, hypoxemia, sepsis, or disseminated features; regardless, he needs an airborne isolation room and staff respiratory protection. Obtain sputum for AFB smear/culture and rapid molecular testing before therapy when feasible, then start RIPE therapy plus pyridoxine if he is unstable or the clinical suspicion is high enough to justify empiric treatment. He is admitted for isolation, diagnostic completion, and public-health coordination rather than returned to the hallway or discharged without a controlled follow-up plan.
Patient Presentation to Attending
“This is a 42-year-old man with two months of 9-kg weight loss, drenching night sweats, chronic cough, and new blood-streaked sputum. He was born in a TB-endemic region and has no abrupt fever, pleuritic pain, or witnessed aspiration; his radiograph shows an upper-lobe cavitary process. He is currently oxygenating adequately without shock or active massive hemoptysis, but this is highly concerning for contagious pulmonary TB. I recommend immediate airborne isolation, N95 precautions, three sputum specimens with AFB studies and rapid MTB/rifampin testing, HIV testing, and infectious-disease/public-health consultation. If he becomes unstable or the suspicion remains high after specimens are obtained, I would begin weight-based isoniazid, rifampin, pyrazinamide, ethambutol, and pyridoxine and admit him for monitored care.”
Study Directive
Draw the ED pathway for suspected pulmonary TB: isolate → assess severity → collect specimens → notify public health → treat/admit.
Memorize the four first-line drugs and the major toxicity of each.
Review local criteria for discontinuing airborne isolation and the role of NAAT.
Practice three cases involving HIV, miliary disease, and TB meningitis; state what changes in disposition and treatment urgency.
Key Medications
Isoniazid: 5 mg/kg PO daily, maximum 300 mg/day.
Rifampin: 10 mg/kg PO daily, maximum 600 mg/day.
Pyrazinamide: 25 mg/kg PO daily; maximum commonly 2 g/day, with renal-adjusted intermittent regimens as needed.
Ethambutol: 15–20 mg/kg PO daily; maximum commonly 1.6 g/day initially, adjusted for renal function and specialist guidance.
Pyridoxine: 25–50 mg PO daily with isoniazid.
Doses vary with weight, renal function, hepatic disease, pregnancy, and intermittent therapy; verify with Lexicomp, UpToDate, or the local TB program. Pediatric and HIV-associated regimens require specialist guidance.
High-Yield Pearls
A negative AFB smear does not exclude TB; culture and molecular testing remain essential.
Collect diagnostic specimens before empiric therapy when the patient is stable, but never allow testing logistics to delay treatment in unstable disease.
The emergency department diagnosis includes an exposure-control plan—not merely an antibiotic prescription.
The Mimics
Lung cancer — persistent focal mass, smoking history, and lack of infectious constitutional pattern; confusing it can delay tissue diagnosis while assuming a negative TB test is definitive.
Bacterial necrotizing pneumonia — abrupt fever, toxicity, and rapid radiographic progression; confusing it can delay airborne precautions and multidrug therapy.
Fungal infection — compatible geography or immunosuppression with nodules/cavities; confusing it can lead to the wrong antimicrobial regimen.
Nontuberculous mycobacterial disease — chronic cough with negative TB molecular testing and characteristic bronchiectatic/nodular disease; confusing it can expose the patient to unnecessary toxic TB therapy.
Board Question
A patient with suspected contagious pulmonary tuberculosis is clinically stable and has not yet received therapy. Which infection-control measure is most appropriate?
AStandard precautions only
BContact precautions with a surgical mask for staff
CDroplet precautions in a shared room
DAirborne isolation with a fit-tested N95 or higher-level respirator
Reveal answer
Correct: D
Mycobacterium tuberculosis is transmitted by airborne droplet nuclei that can remain suspended in the air. The patient requires an airborne infection isolation room and appropriately fit-tested respiratory protection for staff.
Use this current multisociety guideline to select evidence-based regimens for drug-susceptible and drug-resistant tuberculosis after initiating airborne isolation and involving public health and infectious-disease specialists.
Pneumonia is a common cause of respiratory failure and sepsis, but inappropriate antibiotic selection, delayed administration, and failure to identify...
A 68-year-old woman arrives with a winter coat still zipped to her chin, breathing fast enough that each sentence breaks into fragments. Her fingers are cool, her cough produces rust-colored sputum, and the pulse oximeter flashes 84% despite a nonrebreather mask. Her daughter says the patient was independent yesterday but became confused overnight. The antibiotic decision has not yet been made.
Before You Read
Which findings make pneumonia a sepsis emergency rather than a routine infection?
What empiric regimen fits the patient’s setting and risk factors?
When does “aspiration” require anaerobic coverage—and when does it not?
Why It Matters
Pneumonia is a common cause of respiratory failure and sepsis, but inappropriate antibiotic selection, delayed administration, and failure to identify resistant pathogens all worsen outcomes. The right regimen is determined by severity, acquisition setting, comorbidity, and prior microbiology—not by the radiograph alone.
When to Think of It
Suspect pneumonia with acute cough, fever or hypothermia, dyspnea, pleuritic pain, sputum, hypoxemia, focal crackles, delirium, or a new infiltrate. Older adults may present with weakness, falls, anorexia, or confusion without fever or cough.
Sick or Not Sick
The key fork is adequate oxygenation and perfusion versus severe pneumonia with respiratory failure or sepsis. The single most important call is whether the patient needs immediate ventilatory support and sepsis-level resuscitation, not whether the infiltrate is “large.”
The First Fifteen Minutes
Hypoxemia → nasal cannula 1–6 L/min, escalating to a nonrebreather at 10–15 L/min or high-flow nasal oxygen per local protocol; oxygen restores the diffusion gradient while definitive therapy begins.
Persistent hypoxemia with increased work of breathing but preserved airway protection → high-flow nasal cannula, because it delivers more reliable FiO₂ and modest positive pressure.
Severe community-acquired pneumonia requiring ICU admission → ceftriaxone 2 g IV once daily plus azithromycin 500 mg IV once daily, covering typical bacteria and atypical pathogens; give promptly after cultures if this does not create a meaningful delay.
Severe immediate beta-lactam allergy → levofloxacin 750 mg IV once daily as an alternative; fluoroquinolone selection requires attention to QT prolongation, tendinopathy, aortic risk, and local resistance.
Risk for MRSA—prior MRSA respiratory isolation, recent hospitalization with IV antibiotics, or severe necrotizing/post-influenza pattern—→ vancomycin 15–20 mg/kg IV once, then pharmacy-guided dosing, because it covers resistant gram-positive disease. Dose and monitoring vary with renal function; check an institutional protocol.
Risk for Pseudomonas or hospital-acquired infection—recent IV antibiotics, structural lung disease, prior Pseudomonas, or hospitalization-associated pneumonia—→ cefepime 2 g IV every 8 hours or piperacillin-tazobactam 4.5 g IV every 6 hours, because antipseudomonal beta-lactam coverage is required. Adjust for renal function and local antibiogram.
Septic shock or hypoperfusion → balanced crystalloid 30 mL/kg IV, with frequent reassessment for overload; fluid restores circulating preload but should not be given blindly in severe cardiac or renal failure.
Persistent hypotension after fluids → norepinephrine 0.05–0.1 mcg/kg/min IV infusion, titrated to a MAP generally ≥65 mmHg, because alpha-adrenergic vasoconstriction restores perfusion with less tachyarrhythmia than dopamine.
Aspiration with abscess, empyema, or severe periodontal disease → ampicillin-sulbactam 3 g IV every 6 hours; routine anaerobic coverage is not required for uncomplicated aspiration pneumonia without these features.
Definitive Care & Disposition
Obtain blood cultures and a good lower-respiratory specimen in severe disease or when resistant organisms are suspected, but do not delay antibiotics for difficult collection. Use lactate, renal function, blood gas when indicated, imaging, and repeated examination to guide severity. Narrow therapy when cultures and clinical response permit; uncomplicated CAP often receives a minimum of about 5 days with clinical stability before stopping, while empyema, abscess, bacteremia, or resistant pathogens require longer specialist-guided courses. ICU indications include mechanical ventilation, vasopressors, severe hypoxemia, shock, or multiple minor severity criteria. Drain empyema and address obstruction or foreign material—antibiotics alone are inadequate source control.
How This One Kills
The critical miss is treating the radiograph while overlooking respiratory fatigue: a patient with escalating oxygen needs and altered mentation can progress from “pneumonia” to arrest while repeated antibiotic adjustments distract from intubation or source control.
The Atypical Presentation
Older adults, immunocompromised patients, and those with renal disease may be afebrile and have only delirium, weakness, tachypnea, or hypoxemia. A normal white count does not reassure, and a single portable radiograph may undercall early or posterior disease. Let respiratory rate, oxygen requirement, perfusion, mental status, and trajectory drive urgency; use microbiology and response to refine—not replace—the initial clinical judgment.
Back to Our Patient
Back to the 68-year-old woman with fragmented speech, confusion, cool extremities, and oxygen saturation of 84% on a nonrebreather: she has severe pneumonia with impending respiratory failure and possible septic shock. Risk stratification, not the sputum color, drives the next move—prepare for intubation or escalation of respiratory support, obtain cultures if immediately feasible, give balanced crystalloid with reassessment, and start ceftriaxone 2 g IV plus azithromycin 500 mg IV without delay. If hypotension persists after fluids, begin norepinephrine; assess for MRSA or Pseudomonas risk before adding vancomycin or an antipseudomonal agent. She requires ICU admission, with de-escalation and evaluation for empyema or another source as data return.
Patient Presentation to Attending
“This is a 68-year-old woman with abrupt cough, rust-colored sputum, dyspnea, and new confusion, now tachypneic with an oxygen saturation of 84% on a nonrebreather. She has no known aspiration event, unilateral leg swelling, or preceding orthopnea, but her daughter reports rapid decline from baseline. She is cool, speaks in fragments, and has focal right basilar crackles with persistent hypoxemia. I am concerned for severe community-acquired pneumonia causing acute hypoxemic respiratory failure and sepsis, with pulmonary embolism and cardiogenic edema as alternatives. I would prepare for definitive airway management, obtain cultures and lactate without delaying therapy, administer ceftriaxone and azithromycin, give carefully reassessed crystalloid, start norepinephrine for persistent shock, and admit her to the ICU.”
Study Directive
Build empiric regimens for nonsevere CAP, severe CAP, aspiration pneumonia, HAP, MRSA risk, and Pseudomonas risk.
Memorize ceftriaxone/azithromycin doses and the triggers for adding vancomycin or antipseudomonal coverage.
Practice recognizing when pneumonia requires intubation, vasopressors, drainage, or ICU admission.
Review your institution’s antibiogram and antibiotic de-escalation policy.
Key Medications
Ceftriaxone: 2 g IV every 24 hours.
Azithromycin: 500 mg IV or PO daily.
Levofloxacin: 750 mg IV or PO daily; adjust for renal function and check QT-risk factors.
Vancomycin: 15–20 mg/kg IV loading dose, then pharmacy/AUC-guided dosing; meaningful variability requires an institutional protocol or Lexicomp/UpToDate.
Cefepime: 2 g IV every 8 hours for severe antipseudomonal coverage; renal adjustment is essential.
Piperacillin-tazobactam: 4.5 g IV every 6 hours; extended-infusion and renal-adjusted regimens vary by institution.
Ampicillin-sulbactam: 3 g IV every 6 hours for aspiration pneumonia with anaerobic-risk features.
Norepinephrine: start 0.05–0.1 mcg/kg/min IV and titrate to perfusion/MAP.
Pediatric pneumonia regimens are weight-based and differ substantially; consult a pediatric reference.
High-Yield Pearls
Oxygen requirement and work of breathing are often more prognostic than fever or leukocytosis.
“Aspiration” is an event; anaerobic coverage is a decision based on abscess, empyema, necrosis, or severe dental disease.
Broad therapy should have an exit plan: obtain cultures when indicated and narrow once the pathogen and clinical trajectory are clear.
The Mimics
Pulmonary embolism — disproportionate dyspnea, pleuritic pain, or hypoxemia with a minimal infiltrate; confusing it can delay anticoagulation or reperfusion therapy.
Cardiogenic pulmonary edema — orthopnea, diffuse B-lines, edema, and cardiac history; confusing it can worsen volume overload with unnecessary fluids.
Atelectasis — volume loss and rapid radiographic change; confusing it can cause unnecessary broad-spectrum antibiotics.
Organizing or inflammatory pneumonitis — subacute symptoms with poor antibiotic response; confusing it can delay immunomodulatory or specialty evaluation.
Board Question
A 74-year-old man develops pneumonia after vomiting during a seizure. He is febrile and hypoxemic, with a dependent-lobe infiltrate but no abscess, empyema, severe periodontal disease, or putrid sputum. Which empiric regimen is most appropriate?
ACeftriaxone plus metronidazole solely because aspiration occurred
BAmpicillin-sulbactam or a standard CAP regimen based on severity
CVancomycin monotherapy
DClindamycin monotherapy for all aspiration events
Reveal answer
Correct: B
Aspiration pneumonitis and uncomplicated aspiration pneumonia do not automatically require additional anaerobic coverage. Add dedicated anaerobic therapy when abscess, empyema, necrosis, or major periodontal disease is present.
Use this updated ATS guideline to guide empiric antibiotic selection, diagnostic testing, and treatment decisions for adults with community-acquired pneumonia.
4 of 4
ARDS Network Ventilator Protocol
ARDS management is a balance between correcting life-threatening hypoxemia and preventing ventilator-induced lung injury. A small set of protocolized...
A 55-year-old man lies motionless beneath the ventilator’s tubing, his skin warm and mottled, the monitor showing an oxygen saturation of 86% despite high inspired oxygen. He was admitted yesterday with septic shock; now both lungs look diffusely white on the portable film. The ventilator reports a plateau pressure of 34 cm H₂O, and each attempt to raise the tidal volume worsens the alarms. The next ventilator adjustment has not yet been made.
Before You Read
How do you select tidal volume when the patient’s actual weight is misleading?
Which pressure target limits ventilator-induced lung injury?
When should you prone, increase PEEP, or use rescue therapies?
Why It Matters
ARDS management is a balance between correcting life-threatening hypoxemia and preventing ventilator-induced lung injury. A small set of protocolized actions—low tidal volume, plateau-pressure limitation, appropriate PEEP, and timely proning—improves survival.
When to Think of It
ARDS is acute hypoxemic respiratory failure with bilateral opacities not fully explained by effusion, collapse, or heart failure, developing within one week of a known insult such as sepsis, pneumonia, aspiration, trauma, pancreatitis, or transfusion. Evaluate for nonpulmonary edema, infection, pulmonary embolism, and cardiogenic causes rather than assuming every bilateral infiltrate is ARDS.
Sick or Not Sick
The key call is mild/moderate disease responsive to lung-protective ventilation versus severe refractory hypoxemia or ventilator-induced injury. Track PaO₂/FiO₂, plateau pressure, driving pressure, compliance, hemodynamics, and trajectory; severe ARDS generally means PaO₂/FiO₂ ≤100 on PEEP ≥5 cm H₂O.
The First Fifteen Minutes
Set tidal volume at 6 mL/kg predicted body weight (PBW), not actual weight; PBW approximates lung size and reduces volutrauma.
Plateau pressure >30 cm H₂O → decrease tidal volume by 1 mL/kg PBW steps to a minimum of 4 mL/kg, because limiting alveolar distending pressure reduces overdistension.
Persistent hypoxemia → increase FiO₂ temporarily to 1.0, then titrate down as soon as possible to an SpO₂ roughly 88–95% or PaO₂ 55–80 mmHg; excessive oxygen can contribute to toxicity.
Moderate-to-severe ARDS → use a higher-PEEP strategy, titrating PEEP to improve oxygenation and recruitable lung while monitoring blood pressure and compliance; the exact PEEP/FiO₂ table varies by protocol.
PaO₂/FiO₂ <150 with FiO₂ ≥0.6 and PEEP ≥5 despite optimization → prone positioning for 16 hours/day, because prone ventilation improves dorsal recruitment and ventilation-perfusion matching.
Patient-ventilator dyssynchrony or unsafe spontaneous effort despite analgesia/sedation → cisatracurium 15 mg IV bolus, then 37.5 mcg/kg/min IV infusion for up to 48 hours, because neuromuscular blockade can facilitate controlled lung-protective ventilation. This dose has meaningful protocol variation; verify with Lexicomp, UpToDate, or institutional policy.
Pain or agitation interfering with safe ventilation → fentanyl 25–100 mcg IV bolus, then 25–200 mcg/hour IV infusion, because analgesia reduces distress and ventilatory drive; titrate to the lightest effective sedation.
Persistent agitation despite analgesia → propofol 5–50 mcg/kg/min IV infusion, because it provides rapidly titratable sedation; monitor hypotension, triglycerides, and infusion duration.
If shock is present, prioritize perfusion and avoid reflexively increasing PEEP when it is causing hemodynamic collapse.
Definitive Care & Disposition
Use volume assist-control or an equivalent mode capable of reliable tidal-volume delivery. Recheck blood gas, plateau pressure, compliance, and hemodynamics after major changes. Use conservative fluid management after shock is controlled. Prone severe ARDS early and continue daily sessions until oxygenation improves. Consider corticosteroids, inhaled pulmonary vasodilators as a bridge, recruitment strategies, or VV-ECMO only with ICU/pulmonary expertise and local protocol; inhaled vasodilators improve oxygenation transiently but have not established mortality benefit. Treat the underlying cause, prevent VTE and stress-related complications when indicated, and pursue daily awakening and spontaneous-breathing assessments when safe.
How This One Kills
The characteristic failure is escalating tidal volume to “normalize” PaCO₂ or oxygen saturation despite plateau pressure above 30 cm H₂O, converting an injured but recruitable lung into progressive ventilator-induced lung injury.
The Atypical Presentation
ARDS may begin with modest infiltrates and worsening oxygen requirement before the chest radiograph becomes dramatic. Obesity makes actual body weight especially misleading, while neuromuscular weakness, chest-wall disease, or high abdominal pressure can elevate plateau pressure without identical lung overdistension. Use PBW, serial plateau pressure, compliance, driving pressure, gas exchange, and the clinical trigger together rather than treating a single number in isolation.
Back to Our Patient
Back to the 55-year-old man with septic shock, diffuse opacities, saturation 86%, and a plateau pressure of 34 cm H₂O: he has severe ARDS with unsafe ventilator pressures. Recognize the acute bilateral process in the setting of sepsis, then risk-stratify by severe hypoxemia and plateau pressure; immediately reduce tidal volume from 6 mL/kg PBW in 1 mL/kg steps toward 4 mL/kg while accepting permissive hypercapnia if pH remains clinically tolerable. Use temporary FiO₂ 1.0, protocolized higher PEEP with hemodynamic monitoring, and prone positioning for 16 hours if PaO₂/FiO₂ remains <150; use fentanyl and propofol for comfort, with cisatracurium if dyssynchrony prevents safe ventilation. He remains in the ICU for ongoing lung-protective ventilation, treatment of sepsis, conservative fluid management after shock resolution, and reassessment for rescue therapies.
Patient Presentation to Attending
“This is a 55-year-old man with septic shock and acute hypoxemic respiratory failure, now intubated with diffuse bilateral opacities and an oxygen saturation of 86% on high FiO₂. His plateau pressure is 34 cm H₂O, with no evidence so far of an isolated pneumothorax or unilateral obstruction, and the timing strongly supports severe ARDS from sepsis. I would calculate predicted body weight, reduce tidal volume in 1-mL/kg steps toward 4–6 mL/kg PBW, temporarily use FiO₂ 1.0, and titrate PEEP with close blood-pressure monitoring. If his P/F ratio remains below 150 on FiO₂ at least 0.6, I would initiate prolonged prone positioning; I would use analgesia and sedation, and reserve cisatracurium for unsafe dyssynchrony. He requires continued ICU care with serial plateau pressure, gas exchange, compliance, and hemodynamic reassessment.”
Study Directive
Calculate PBW for five male and female heights and select the starting tidal volume.
Practice adjusting tidal volume, respiratory rate, FiO₂, and PEEP when plateau pressure or pH becomes unacceptable.
Memorize the indications for prone positioning and the safety checklist for turning a ventilated patient.
Review your ICU’s ARDS PEEP/FiO₂ table and demonstrate a plateau-pressure measurement on a ventilator.
Key Medications
Fentanyl: 25–100 mcg IV bolus; infusion commonly 25–200 mcg/hour, titrated to analgesia and sedation goals.
Propofol: 5–50 mcg/kg/min IV infusion; monitor hypotension, hypertriglyceridemia, and propofol infusion syndrome.
Cisatracurium: 15 mg IV bolus, then 37.5 mcg/kg/min infusion in a commonly used severe-ARDS regimen; dosing varies by protocol and requires adequate analgesia/sedation and neuromuscular monitoring.
Norepinephrine for concurrent shock: start 0.05–0.1 mcg/kg/min IV and titrate to perfusion/MAP.
Corticosteroid regimens in ARDS vary substantially by timing, cause, and institutional protocol; verify with ICU guidance rather than using a single universal dose.
Pediatric ARDS uses age-specific PALICC-based targets and should not be managed by directly transplanting adult protocol doses.
High-Yield Pearls
Tidal volume is based on predicted—not actual—body weight; this is a frequent bedside and board-exam error.
In severe ARDS, timely proning is not a last-minute rescue maneuver—it is an early mortality-reducing intervention.
The Mimics
Cardiogenic pulmonary edema — elevated filling pressures, rapid response to diuresis/afterload reduction, or supportive echocardiography; confusing it can lead to inappropriate high-PEEP strategies while missing cardiac treatment.
Diffuse alveolar hemorrhage — falling hemoglobin, hemoptysis, renal findings, or bloody bronchoalveolar lavage; confusing it can delay immunologic evaluation.
Pulmonary embolism — sudden hemodynamic collapse, RV strain, and relatively clear lungs early; confusing it can delay anticoagulation or reperfusion.
Diffuse pneumonia without ARDS — focal or evolving infectious pattern with less severe compliance impairment; confusing it can obscure the need to treat the precipitating infection and reassess the diagnosis.
Board Question
A 70-kg predicted-body-weight patient with ARDS is receiving a tidal volume of 420 mL. His plateau pressure is 34 cm H₂O. Which ventilator change is most appropriate?
AIncrease tidal volume to improve CO₂ clearance
BDecrease tidal volume to 350 mL and reassess plateau pressure
CIncrease respiratory rate only after increasing tidal volume
DSwitch immediately to pressure-support ventilation
Reveal answer
Correct: B
The initial lung-protective tidal volume is 6 mL/kg PBW, and a plateau pressure above 30 cm H₂O requires reducing tidal volume in 1-mL/kg steps, potentially to 4 mL/kg PBW. Hypercapnia may be accepted if clinically tolerable; respiratory rate can be adjusted separately.
Yesterday’s Differential
The daily puzzle — from editions past
A quick test of recall from prior editions. Commit to an answer before you check.
From yesterday's edition
A 66-year-old man presents with an hour of central chest pressure and diaphoresis. He is pale but hemodynamically stable. What’s the diagnosis, and the first move?
Check your answer
Bifascicular Block. Treat new bifascicular block in a chest-pain patient as an acute coronary occlusion equivalent — activate the ACS pathway and discuss emergent catheterization even without ST elevation. Any patient with bifascicular block plus syncope or presyncope is admitted for monitoring; if the syncope workup is otherwise unrevealing, pacemaker insertion is recommended.
From the July 29 edition
Today, three days ago: Nicardipine. What’s the adult ED dose, and the contraindication you’d most regret missing?
Check your answer
Start 5 mg/h IV; increase by 2.5 mg/h every 5–15 min to max 15 mg/h, then reduce to maintenance once target BP reached. Advanced aortic stenosis; hypersensitivity.
From the July 22 edition
A 29-year-old man with recurrent nocturnal syncope has a type 1 Brugada ECG during a temperature of 39.2°C. He develops recurrent polymorphic VT with a pulse despite two synchronized shocks. Which therapy is most appropriate next?
AProcainamide infusion
BIsoproterenol infusion
CVerapamil bolus
DAdenosine bolus
Reveal answer
Correct · B
Isoproterenol infusion. In Brugada electrical storm, β-adrenergic stimulation can suppress recurrent VF by increasing inward calcium current. Procainamide and other sodium-channel blockers may worsen the substrate; unstable or pulseless rhythms still require immediate defibrillation.
Journal Watch
From the FOAMed wire
No new items in the last week. The wire resumes when sources update.
In this episode, Sam Ashoo, MD and Dr. T.R. Eckler, MD discuss the July 2026 Emergency Medicine Practice article, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management in the Emergency Department . 0:17 – Intro & sponsor promo 1:09 – Episode introduction 4:03 – Definitions: SJS vs. TEN vs. "overlap" by body surface area 6:12 –...
Jenny Beck-Esmay and Matthew DeLaney step in for the main show this month, covering 20 papers in depth. Aaron Skolnik joins Jess Monas for the Ultra Summary. Ken and Swami look at an article by Chris Carpenter et al....
UMEM Pearl
Matched to today’s topics
A clinical pearl from the University of Maryland EM group’s Educational Pearls, tied to today’s differential.
For patients entering an ARDSNet ventilation pathway, the S:F ratio offers a rapid, noninvasive estimate of oxygenation severity when an ABG—and thus a P:F ratio—is not yet available.
PaO2 to FiO2 (P:F) ratios, are often considered the gold standard in critical care for assessing the degree of oxygen-refractory hypoxia in various pathologies, particularly ARDS. P:F does have some limitations, including not accounting for the PEEP, but probably the most limiting is that it requires collecting an ABG, which is invasive and not always feasible or a top priority when resuscitating a critically ill hypoxic patient. On the other hand, SpO2 (pulse ox saturation) is routinely available, and of course the FiO2 should be known, so many have suggested perhaps using an SpO2 to FiO2 (S:
Critical Care Corner
Matched to today’s topics
A critical-care reference from LITFL’s Critical Care Compendium, tied to today’s differential.
Ventilator waveform analysis turns the ARDS Network protocol from a settings checklist into bedside physiology, revealing dyssynchrony, flow starvation, auto-PEEP, and excessive airway pressures during lung-protective ventilation.
Ventilator Waveform Analysis
Pharmacology Corner
Two drugs for the shift
One antimicrobial and one other ED workhorse — selected daily, with sources and last-reviewed dates so every dose is cross-checkable.
Antimicrobial of the Day
Aztreonam
Monobactam (IV)
Indication
Gram-negative and Pseudomonas coverage in patients with severe beta-lactam allergy. Gram-negative spectrum only — no gram-positive or anaerobic activity.
What’s your dose? — reveal dosing & cautions
ED Dose
1–2 g IV q8h. Severe/Pseudomonal infection: 2 g IV q6–8h.
Renal Adjustment
Reduce dose when CrCl < 30 mL/min; HD: supplemental dose after dialysis.
Contraindications
Hypersensitivity to aztreonam.
Interactions
Minimal.
Monitoring
Renal function, CBC.
ED Pearl
Aztreonam has no meaningful cross-reactivity with penicillins or cephalosporins — except ceftazidime, with which it shares a side chain — making it the go-to gram-negative agent in true severe beta-lactam allergy. Pair it with a gram-positive agent when needed.
RSI paralysis, ventilator synchrony paralysis in selected intubated patients, and alternative to succinylcholine when contraindications exist.
What’s your dose? — reveal dosing & cautions
ED Dose
RSI: 1.0–1.2 mg/kg IV using actual body weight in many ED protocols. Lower doses 0.6 mg/kg have slower onset and longer time to ideal intubating conditions.
Renal Adjustment
No formal single-dose adjustment, but duration may be prolonged in hepatic/renal dysfunction.
Contraindications
Hypersensitivity to rocuronium/aminosteroid NMBAs. Cannot intubate/cannot ventilate risk is a clinical contraindication to paralysis without rescue plan.
Continuous sedation/analgesia while paralyzed, train-of-four if ongoing, ventilator/airway security.
ED Pearl
Roc lasts much longer than etomidate or ketamine — paralysis without analgesia/sedation is a never-event you prevent with orders before intubation.
For educational use only. Verify dosing against the FDA label and your institution’s pharmacy resources before administering.
ECG of the Day
Rhythm
Atrial Fibrillation
Irregularly irregular rhythm without organized P waves — management depends on stability, duration, trigger, and stroke risk.
The Tracing
A 74-year-old woman with pneumonia presents tachycardic and short of breath. The ECG shows an irregularly irregular narrow-complex rhythm at 142 bpm with no consistent P waves and a fibrillatory baseline. Her blood pressure is stable, but she is febrile and hypoxic. The rhythm is real, but the infection is driving it.
Fibrillatory baseline may be visible, especially in V1
QRS is usually narrow unless baseline bundle branch block, aberrancy, pre-excitation, or ventricular pacing is present
Ventricular rate can be slow, controlled, rapid, or extremely rapid in pre-excited AF
Pearls
Treat the patient, not just the rate. Sepsis, PE, alcohol withdrawal, thyrotoxicosis, pain, hypovolemia, and hypoxia commonly drive AF with RVR.
Unstable AF gets synchronized cardioversion when the rhythm is causing instability.
Irregular wide-complex AF should trigger a pre-excitation check before AV nodal blockers.
Pitfalls
Do not cardiovert stable AF of unclear duration without thinking about anticoagulation/stroke risk and local protocol.
Do not miss atrial flutter with variable block; it can look irregular.
Do not reflexively stack AV nodal blockers in a patient whose RVR is compensatory for shock.
At the Bedside
Determine stability first. If unstable from AF, cardiovert. If stable, treat triggers, choose rate/rhythm strategy per duration/comorbidities, and address anticoagulation/disposition.
For educational use only. Verify ECG interpretation against the LITFL entry and your institution’s practice before clinical decision-making.
Case of the Day
From the lead · Pertussis
Self-Examination
Test Your Understanding
A 2-month-old unimmunized infant has recurrent apnea and cyanosis, with minimal cough. The mother has had a persistent cough for 4 weeks. Which is the most appropriate next step?
ADischarge after a normal chest radiograph
BGive a 5-day course of azithromycin and provide routine follow-up
CBegin continuous monitoring, respiratory support as needed, and treat for suspected pertussis
DGive nebulized albuterol and systemic corticosteroids only
Reveal answer
Correct answer · C
Infants may present with apnea and cyanosis without a classic whoop and are at high risk for rapid deterioration. They require monitoring, supportive respiratory care, droplet precautions, and macrolide therapy; household contacts also require evaluation and prophylaxis.
Study Pace4 topics today; Issue 18 of 94 — Pulmonary (Week 10)Deadline · June 1, 2026